Carolyn A Young, Dawn Langdon, David Rog, Suresh Kumar Chhetri, Radu Tanasescu, Seema Kalra, Gillian Webster, Richard Nicholas, Helen L Ford, John Woolmore, David Paling, Alan Tennant, Roger Mills
BACKGROUND: The prevalence of depression in Multiple Sclerosis (MS) is often assessed by administering patient reported outcome measures (PROMs) examining depressive symptomatology to population cohorts; a recent review summarised 12 such studies, eight of which used the Hospital Anxiety and Depression Scale-Depression (HADS-D). In clinical practice, depression is diagnosed by an individual structured clinical interview; diagnosis often leads to treatment options including antidepressant medication...
April 26, 2024: Multiple Sclerosis and related Disorders